CLVS
Marshall Wace’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-310,123
| Closed | -$370K | – | 3422 |
|
|
2022
Q3 | $370K | Buy |
310,123
+223,880
| +260% | +$267K | ﹤0.01% | 2151 |
|
|
2022
Q2 | $155K | Buy |
+86,243
| New | +$155K | ﹤0.01% | 2502 |
|
|
2019
Q4 | – | Sell |
-63,476
| Closed | -$249K | – | 2126 |
|
|
2019
Q3 | $249K | Buy |
+63,476
| New | +$249K | ﹤0.01% | 1200 |
|
|
2019
Q1 | – | Sell |
-36,184
| Closed | -$650K | – | 2135 |
|
|
2018
Q4 | $650K | Buy |
36,184
+21,787
| +151% | +$391K | 0.01% | 1021 |
|
|
2018
Q3 | $423K | Buy |
+14,397
| New | +$423K | ﹤0.01% | 955 |
|
|
2017
Q4 | – | Sell |
-18,567
| Closed | -$1.52M | – | 497 |
|
|
2017
Q3 | $1.52M | Buy |
18,567
+12,426
| +202% | +$1.02M | 0.07% | 187 |
|
|
2017
Q2 | $577K | Buy |
+6,141
| New | +$577K | 0.03% | 226 |
|
|
2017
Q1 | – | Sell |
-83,014
| Closed | -$3.69M | – | 830 |
|
|
2016
Q4 | $3.69M | Sell |
83,014
-82,723
| -50% | -$3.67M | 0.02% | 537 |
|
|
2016
Q3 | $5.98M | Buy |
+165,737
| New | +$5.98M | 0.04% | 375 |
|
|
2015
Q4 | – | Sell |
-8,208
| Closed | -$755K | – | 1168 |
|
|
2015
Q3 | $755K | Buy |
+8,208
| New | +$755K | 0.01% | 670 |
|
|
2014
Q4 | – | Sell |
-4,642
| Closed | -$211K | – | 1025 |
|
|
2014
Q3 | $211K | Buy |
+4,642
| New | +$211K | ﹤0.01% | 772 |
|